Why Canada is suspending use of AstraZeneca vaccine in people under 55

Canada’s vaccine advisory committee is recommending immediately suspending the use of the AstraZeneca-Oxford COVID-19 vaccine in Canadians under 55, following reports of rare but potentially fatal blood clots in Europe that appear to be connected to the shot.

This post was originally published on this site